WCC 2006 - Slides

Slides of the World Congress of Cardiology 2006

Title	Author	Session Number
Acute Coronary Syndromes	Kristensen	FP4839
Acute reperfusion treatment of ST-elevation myocardial infarction	VanDeWerf	FP995
AFFIRM study - evaluation of LAA stunning	Colonna	FP119
AHF Syndrom - epidemiology	Gheorghiade	FP4853
Aims and design of EuroAction	Kotseva	FP2545
Arrhythmias	Linde	FP4838
Basic Science	Sipido	FP4835
Benefit of Fondaparinux on mortality, ischaemic events and bleeding across the entire spectrum	Mehta	FP1745
Best management in rural areas	Nordrehaug	FP2525
Best management in urban areas	Montalescot	FP2524
Biomarker strategy in acute coronary syndromes	Lindahl	FP1385
Changes in in-hospitial treatment of heart failure	Tavazzi	FP2538
Clinical profile and in-hospital mortality of patients with acute heart failure	Nieminen	FP2537
Comparing chronic heart failure guidelines - Similarities and differences	Swedberg	P2
congress-documents
C-reactive protein	Biasucci	1753
Current use of percutaneous coronary intervention in Europe	Marco	FP2532
Definition of multivessel disease	Eeckhout	FP149
Definitions of the Metabolic Syndrome	Alberti	1764
DES versus BMS: an evidence-based approach to stent selection in real-world	Marco	FP4826
Determinants of new onset diabetes among hypertensive patients	Gupta	FP4827
Determinants of new onset diabetes among hypertensive patients	Zamorano-Gomez	FP4828
Discussant on WAVE	Verheugt	FP3412
Drug options	Tavazzi	FP1748
Effect of pioglitazone in stroke prevention in type 2 diabetes	Wilcox	FP120
Effect on mode and cause of death of initiation of treatment for chronic heart failure	Tavazzi	FP4832
Effect on mode and cause of death of initiation of treatment for chronic heart failure	Willenheimer	FP4831
Effects of Pioglitazone in patients with or without a history of stroke	Ryden
Elevation of troponins in acute heart failure: injury or infarct?	Mair	P136
Embolic events in patients with atrial fibrillation and effective anticoagulation	Zahn	FP117
Epidemiology	Senni	FP3433
ESC Guidelines: challenges for the future	Priori	FP979
Establishing networks for Acute Myocardial Infarction	Elsaesser	FP2526
Factor Xa inhibitors in atrial fibrillation	Turpie	FP1825
GIK in AMI after CREATE-ECLA and OASIS 6 - Discussant	Lablanche	FP125
Guidelines revisited	VanDeWerf	FP2523
Heart failure - renal dysfunction	VanVeldhuisen	FP3441
Heart failure and cardiomyopathies	Ponikowski	FP4842
HF with preserved ejection fraction - Diagnosis in daily practice	Fraser	FP3436
Home or Hospital in Heart failure - the HHH study	Swedberg	FP991
Hope 2 - Update. Discussant	Hall	FP129
How to identify patients at high risk for stroke	Weimar	FP4844
How to treat percutaneously	Sievert	FP4847
Hypertension and risk factors	Agabiti Rosei	4836
IIb/IIIa receptor blockade -In the cath lab or upstream?	Steinhubl	FP1758
Imaging	Pinto	FP4837
Impact of cath lab availability on outcome of acute coronary syndrome - Pro	Wallentin	FP139
Implantable cardioverter-defibrillator indications	FernandezLozano	FP1749
Implantable cardioverter-defibrillator indications	Swedberg	FP1750
Implications of the EuroAction project for preventive cardiology	Wood	FP2549
Important worldwide differences in outcomes among atherothrombotic patients	Ohman	FP122
Indications of cardiac pacing and resynchronisation therapy	Vardas	FP3409
Individual and community interventions	Schumann	FP1763
Influence of the level of care on presentation and management of AF	Breithardt	FP3427
Interventional cardiology	DeBruyne	FP4840
JIKEI Heart Study - Valsartan in a Japanese population with hypertension	Dahlof-Mochizuki	FP3419
JIKEI Heart Study: what did the study show? Discussant	Girerd	FP3420
Long-term outcomes of STEMI after thrombolysis vs inter-hospital transport for primary PCI	Gitt	FP1742
Long-term pharmacological treatment after acute heart failure in Europe	Ponikowski	FP4857
Management of hypertension and other risk factors in diabetes	Ryden	FP2544
Medical emergency teams	Cokkinos	FP4860
Moving towards a consensus on redefinition of myocardial infarction	Thygesen	FP3408
Multi-slice computed tomography	Vanhoenacker	FP151
Multivessel disease - Invasive evaluation	Fearon	FP152
Neurocardiogenic syncope and heart disease	Brignole	FP4851
New developments in Pentasaccharides in Atrial Fibrillation	DeCaterina	FP1824
New-onset diabetes and antihypertensive drugs	Mancia	FP2543
Niseritide	Dickstein	FP1009
Non-invasive diagnosis	Kownator	FP1004
OASIS 5 + 6 FONDAPARINUX - Discussant	Simoons	FP1746
One year outcome of Acute Coronary Syndrome in Europe 2005	Behar	994
Optimising management of ACS: insights from the new guidelines	Fox	FP4325
Overview of large RCT of ACE inhibitors in stable patients	Dagenais	FP4833
PEP-CHF Primary end-point at one year	Dickstein	FP985
Percutaneous ablation: patient selection, techniques and results	Extramiana	FP5092
Percutaneous coronary intervention in the elderly	Marco	FP3430
Perindopril in elderly people with Chronic Heart Failure	Cleland	FP984
Peri-procedural elevation of troponins	Ravkilde	FP135
PRAGUE 2 Trial - five years follow-up	Widimsky	FP1741
Predictive outcome factors in the real-world management of patients	Montalescot	FP3413
Prevention of bleeding in the setting of coronary artery disease	Mehta	FP1002
Principles of the nurse-led cardiovascular prevention programme	Jennings	FP2546
Refinement of the clinical definition of Myocardial Infarction	Alpert	153
Role of atrial fibrillation ablation in heart failure patients	Jais	FP1829
STEMI patients - results of OASIS 6 study and CREATE-ECLA trial	Diaz	FP124
Syncope and falls in the elderly	Kenny	FP4852
The Availability of a Cath Lab Improves Outcome in ACS Patients	VanDeWerf	FP140
The Availability of a Cath Lab Improves Outcome in ACS Patients	VanDeWerf	FP142
The burden of haemorrhagic complications in patients undergoing cardioversion	Stellbrink	FP118
The Chronic Care Model Applied to Secondary Prevention of Cardiovascular Disease	Pearson	FP987
The myoblast approach	Siminiak	FP2529
The variable anatomy of the veno-atrial junction and left atrial appendage	Ho	FP1102
Thienopyridines after CLARITY-PCI - an update for ST-elevation myocardial infarction	Witkowski	FP1757
Treatment of the metabolic syndrome	Deedwania	FP1767
Troponins in Acute Myocardial Infarction	Giannitsis	FP134
Ultrafiltration	Ponikowski	FP1010
Valvular heart disease in the elderly	Vahanian	FP3431
What drives the prothrombotic state in atrial fibrillation?	VanWagoner	FP1822
Where are we in facilitated percutaneous coronary intervention	VanDeWerf	FP1759